Editas Medicine Inc’s stock market performance has been somewhat irregular. The 1-year high for the company’s stock was recorded at $6.69 on 05/15/24, with the lowest value being $0.91 on 04/07/25. 52-week price history of EDIT Stock Analyzing the 52-week price history of a stock,
The market performance of Editas Medicine Inc’s stock has been turbulent in recent times. Over the last year, the company’s stock reached its highest point at $6.69 on 05/15/24, while the lowest value for the same duration was $0.91 on 04/07/25. 52-week price history of
A stock’s 52-week high and low prices can offer a wealth of information about its current standing and prospective future performance. Editas Medicine Inc’s current trading price is -83.08% away from its 52-week high, while its distance from the 52-week low is 25.81%. The stock’s
Depending on how one views it, the stock price performance for the year has been a mixed bag, resulting in either an optimistic or pessimistic outlook. The index has shown a price loss of -14.17% this year. Over the last six months, there has been
Depending on how one views it, the stock price performance for the year has been a mixed bag, resulting in either an optimistic or pessimistic outlook. The index has shown a price loss of 0.00% this year. Over the last six months, there has been
In terms of market performance, Editas Medicine Inc had a somewhat inconsistent run in. The highest value for the stock in the past year was $8.86 on 03/14/24, while the lowest value was $1.12 on 02/11/25. 52-week price history of EDIT Stock Analyzing the 52-week
Investors’ outlook regarding the stock price performance over the year has been split, with some feeling optimistic and others feeling pessimistic, as it’s been a mixed bag. Until today this year the stock’s price performance recorded an increase of 69.69%. However, over the last six
The performance of the stock price over the year has been up and down, leaving investors with either an optimistic or pessimistic outlook, depending on how they interpret the data. This year’s metric has recorded a Price increase of 58.27%. However, over the past six
In the biotechnology industry, tools for diagnosing health problems and mechanisms for treating them are developed. Biotech products typically require a significant amount of research and funding before they are approved by the FDA (Food and Drug Administration). A drug’s profitability is often discovered years
All rights reserved © 2024, Powered By Smart TechOne
